This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FL8U0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566602223 - CONTRAVE ER 8-90 MG TABLET 120S, with a ceiling value of $11,250.47 and a firm fixed price. The award was made on December 3, 2024, with an ultimate completion date of December 4, 2024.
The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/4/25, 11:29 AM